Nitisinone is a tyrosine degradation inhibitor, playing a crucial role in managing hereditary tyrosinemia type 1 (HT-1). Chemically known as 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione, nitisinone helps prevent the accumulation of toxic metabolites in individuals with HT-1, a rare genetic disorder affecting tyrosine metabolism.
Available in oral formulations, nitisinone is instrumental in maintaining tyrosine levels within safe ranges, preventing liver and kidney damage associated with HT-1. This innovative medication offers a lifeline for those living with this rare condition, enabling a more normal and healthy life.
Despite its efficacy, users should be cautious about potential side effects and adhere to recommended dosages. Regular monitoring is essential to optimise therapeutic benefits while minimising adverse reactions.
Explore the significant impact and benefits of nitisinone confidently, knowing that Index Pharma is dedicated to delivering top-quality pharmaceuticals. Trust our expertise to provide advanced solutions in rare disease management, and choose Index Pharma for superior nitisinone formulations.
Please fill in the enquiry form and we will get back to you immediately.